Biodyne Co. Ltd.
Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, … Read more
Market Cap & Net Worth: Biodyne Co. Ltd. (314930)
Biodyne Co. Ltd. (KQ:314930) has a market capitalization of $253.05 Million (₩370.52 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #16561 globally and #534 in its home market, demonstrating a 5.28% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biodyne Co. Ltd.'s stock price ₩12570.00 by its total outstanding shares 29476760 (29.48 Million).
Biodyne Co. Ltd. Market Cap History: 2021 to 2026
Biodyne Co. Ltd.'s market capitalization history from 2021 to 2026. Data shows growth from $134.48 Million to $253.05 Million (8.08% CAGR).
Index Memberships
Biodyne Co. Ltd. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.61 Billion | 0.09% | #208 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.61 Billion | 0.09% | #208 of 1384 |
Weight: Biodyne Co. Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Biodyne Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biodyne Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Biodyne Co. Ltd.'s market cap is 0.06 times its annual revenue
169.88x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
30.09x
Biodyne Co. Ltd.'s market cap is 30.09 times its annual earnings
830.37x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $134.48 Million | $3.76 Billion | -$10.86 Billion | 0.04x | N/A |
| 2022 | $91.80 Million | $12.21 Billion | $5.61 Billion | 0.01x | 0.02x |
| 2023 | $261.71 Million | $4.09 Billion | -$991.76 Million | 0.06x | N/A |
| 2024 | $324.12 Million | $5.27 Billion | $10.77 Million | 0.06x | 30.09x |
Competitor Companies of 314930 by Market Capitalization
Companies near Biodyne Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Biodyne Co. Ltd. by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $168.62 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #261 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #358 globally with a market cap of $61.21 Billion USD ( €59.64 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #481 globally with a market cap of $44.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $168.62 Billion | $477.73 |
| #261 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #358 | EssilorLuxottica S. A. | PA:EL | $61.21 Billion | €203.10 |
| #481 | Becton Dickinson and Company | NYSE:BDX | $44.89 Billion | $158.08 |
Biodyne Co. Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, Biodyne Co. Ltd.'s market cap moved from $134.48 Million to $ 253.05 Million, with a yearly change of 8.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩253.05 Million | -6.89% |
| 2025 | ₩271.78 Million | -16.15% |
| 2024 | ₩324.12 Million | +23.85% |
| 2023 | ₩261.71 Million | +185.09% |
| 2022 | ₩91.80 Million | -31.74% |
| 2021 | ₩134.48 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Biodyne Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $253.05 Million USD |
| MoneyControl | $253.05 Million USD |
| MarketWatch | $253.05 Million USD |
| marketcap.company | $253.05 Million USD |
| Reuters | $253.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.